Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/86427
DC FieldValueLanguage
dc.contributor.authorMay, Eugenie Wong Soonzh_TW
dc.contributor.authorLin, Szu-Tingzh_TW
dc.contributor.authorLin, Chi-Chenzh_TW
dc.contributor.authorChang, Jo-Fanzh_TW
dc.contributor.authorHung, Ericzh_TW
dc.contributor.authorLo, Yi-Wenzh_TW
dc.contributor.authorLin, Li-Hsunzh_TW
dc.contributor.authorHu, Ren-Yuzh_TW
dc.contributor.authorFeng, Chi-Lunzh_TW
dc.contributor.authorLin, Dai-Yingzh_TW
dc.contributor.authorWu, Shine-Beizh_TW
dc.contributor.authorLee, Wen-Chizh_TW
dc.contributor.authorLyu, Kevin Wzh_TW
dc.contributor.authorChou, Hsiu-Chuanzh_TW
dc.contributor.authorChan, Hong-Linzh_TW
dc.date2014-12-
dc.date.accessioned2015-08-04T03:33:16Z-
dc.date.available2015-08-04T03:33:16Z-
dc.identifier.issn1096-1186zh_TW
dc.identifier.urihttp://hdl.handle.net/11455/86427-
dc.description.abstractDrug resistance is a frequent cause of failure in cancer chemotherapy treatments. In this study, a pair of uterine sarcoma cancer lines, MES-SA, and doxorubicin-resistant partners, MES-SA/DxR-2μM cells and MES-SA/DxR-8μM cells, as a model system to investigate resistance-dependent proteome alterations and to identify potential therapeutic targets. We used two-dimensional differential gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to perform this research and the results revealed that doxorubicin-resistance altered the expression of 208 proteins in which 129 identified proteins showed dose-dependent manners in response to the levels of resistance. Further studies have used RNA interference, H2A.X phosphorylation assay, cell viability analysis, and analysis of apoptosis against reticulocalbin-1 (RCN1) proteins, to prove its potency on the formation of doxorubicin resistance as well as the attenuation of doxorubicin-associated DNA double strand breakage. To sum up, our results provide useful diagnostic markers and therapeutic candidates such as RCN1 for the treatment of doxorubicin-resistant uterine cancer.zh_TW
dc.language.isoenzh_TW
dc.relationPharmacological research : the official journal of the Italian Pharmacological Society, Volume 90, Page(s) 1-17.zh_TW
dc.subjectDIGEzh_TW
dc.subjectDoxorubicinzh_TW
dc.subjectResistancezh_TW
dc.subjectReticulocalbin-1zh_TW
dc.subjectUterine cancerzh_TW
dc.titleIdentification of up- and down-regulated proteins in doxorubicin-resistant uterine cancer cells: reticulocalbin-1 plays a key role in the development of doxorubicin-associated resistancezh_TW
dc.typeJournal Articlezh_TW
dc.identifier.doi10.1016/j.phrs.2014.08.007zh_TW
Appears in Collections:生物醫學研究所
文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.